CELU vs. XBI
Compare and contrast key facts about Celularity Inc. (CELU) and SPDR S&P Biotech ETF (XBI).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CELU or XBI.
Correlation
The correlation between CELU and XBI is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CELU vs. XBI - Performance Comparison
Key characteristics
CELU:
-0.29
XBI:
0.13
CELU:
0.51
XBI:
0.35
CELU:
1.06
XBI:
1.04
CELU:
-0.46
XBI:
0.06
CELU:
-0.80
XBI:
0.34
CELU:
56.58%
XBI:
9.32%
CELU:
158.85%
XBI:
24.48%
CELU:
-98.93%
XBI:
-63.89%
CELU:
-98.34%
XBI:
-47.36%
Returns By Period
In the year-to-date period, CELU achieves a 2.88% return, which is significantly higher than XBI's 1.50% return.
CELU
2.88%
0.00%
-29.98%
-47.68%
-53.79%
N/A
XBI
1.50%
3.23%
-6.49%
-1.85%
-1.12%
3.02%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CELU vs. XBI — Risk-Adjusted Performance Rank
CELU
XBI
CELU vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Celularity Inc. (CELU) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CELU vs. XBI - Dividend Comparison
CELU has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.15%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CELU Celularity Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.15% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
CELU vs. XBI - Drawdown Comparison
The maximum CELU drawdown since its inception was -98.93%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for CELU and XBI. For additional features, visit the drawdowns tool.
Volatility
CELU vs. XBI - Volatility Comparison
Celularity Inc. (CELU) has a higher volatility of 38.66% compared to SPDR S&P Biotech ETF (XBI) at 6.22%. This indicates that CELU's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.